Trial NCT02983097

View at ClinicalTrials.gov 
Org. Study IDs: DSHNHL 2008 R6
Secondary IDs: 2009-010824-25

Last trial update was posted on 2018-01-19

MeSH Interventions

Carboplatin Cytarabine Dexamethasone Lenalidomide Rituximab

MeSH Conditions

Aggression Burkitt Lymphoma Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin

Other Conditions

Aggressive Marginal Zone Lymphoma (MZL) Burkitt Lymphoma (BL) Diffuse Large B-cell Lymphoma (DLBCL) Follicular Lymphoma Grade III (FL III°) Mantle Cell Lymphoma (MCL), Blastoid Variant

Stopping Reasons

Phase II: no scientific interests are given anymore

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID